• CEPI and VBI to develop vaccines against SARS-CoV-2 variants pharmaceutical-technology
    March 12, 2021
    The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines have entered a collaboration to advance the latter’s enveloped virus-like particle (eVLP) vaccine candidates against SARS-CoV-2 variants.
PharmaSources Customer Service